
Overview
USP Zdrowie has been a leader in Poland’s over-the-counter (OTC) medicines and healthcare products market for more than 30 years. The company develops 40 health-related brands, including Ibuprom, Apap and Gripex, and employs 600 people.
- ul. Ryszarda Chomicza 13F, 55-080 Nowa Wieś Wrocławska
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $8,149,085 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 24 days late). All were audited by a statutory auditor.
- 202514/07/2026
- 202411/07/2025
- 202325/06/2024
- 202210/07/2023
- 202108/08/2022
- 202027/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Pharmaceutical products
- Dietary supplements
- Over-the-counter medicines
- Cosmetics
- Immune support products
Websites
- uspzdrowie.plStrona główna – USP ZdrowieWordPressYoast SEO
Trademarks
The company holds 32 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1997.
| Mark | Protected until | |
|---|---|---|
| USP Zdrowie | Jun 12, 2029 | |
| USP Zdrowie | Jun 12, 2029 | |
| Centrum Stworzone dla Zdrowia | Jun 12, 2029 | |
| USP Zdrowie (word) | Jul 25, 2027 | |
| US Pharmacia (word) | Jul 25, 2027 |
Job offers
The company has its own careers page: uspzdrowie.pl/kariera.
Authorized Representatives
Manner of representation
Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Medvic S.a.r.l. | 512,205 | $6,917,949.76 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
Bank accounts
Registered as a VAT taxpayer on 2010-08-17.
61 1090 1056 0000 0001 6754 1421
29 1090 2835 0000 0001 5861 1004
32 1140 2062 0000 5324 7300 1043
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 437.5KPLN 437,492 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 12, 2018 | Call to creditors | |
| Mar 27, 2012 | Call to creditors | |
| Jan 19, 2011 | Merger registered | |
| Sep 9, 2010 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Bausch Health Poland sp. z o.o. | $433,316,311.35 | bauschhealthpoland.pl | ||
| Aflofarm Farmacja Polska sp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Opella Healthcare Poland sp. z o.o. | $228,091,288.55 | opella.com | ||
| Biofarm sp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Angelini Pharma Polska sp. z o.o. | $119,629,315.69 | angelinipharma.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| SUN-Farm sp. z o.o. | $51,063,341.52 | sunfarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-11 | Address change (Poleczki/35, 02-822, Warszawa → Ul. Poleczki 35, 02-822, Warszawa) | |
| 2018-05-29 | Share capital reduction (63,299,550.00 PLN → 25,610,250.00 PLN) | |
| 2017-01-26 | Share capital increase (60,114,900.00 PLN → 63,299,550.00 PLN) | |
| 2015-05-29 | PKD change (Removed: 36 codes) | |
| 2012-07-20 | Share capital reduction (260,114,900.00 PLN → 60,114,900.00 PLN) |
FAQ
Last updated: 2026-10-07


